4D Biomaterials is developing and commercializing resorbable photocurable resins for a wide range of implantable medical device applications. The company's 4Degra biomaterials are 3D printed and tailored based on the needs of the implants, from softer grades for meshes, and films to harder formulations for pins, screws, and load-bearing bone regeneration scaffolds. 4D Biomaterials currently offers three grades of its T-Series material, from the flexible T15 to the most supportive T2500.
A.I. Vali's AIDREA is a versatile AI platform that provides real-time medical image analysis from endoscopy video images and tissue biopsies. The AIDREA platform utilizes proprietary machine learning and deep learning techniques to empower physicians with accurate and reproducible insights that improve clinical care and aid in the early detection of cancer.
AccurKardia is a digital-first and software-only healthcare company focused on enabling a world in which a combination of smart devices, reliable and actionable data, and efficient clinical intervention can together improve medical outcomes and save lives. AccurKardia provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies
AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).
Gregory Fischer, Co-Founder & Chief Science Advisor AiM Medical Robotics
Allheartz is developing novel clinical AI-powered digital solutions to revolutionize home care in musculoskeletal (MSK) and sports health. The Software as a Medical Device (SaMD) platform innovated through the company's proprietary advanced computer vision applications turn an individual's smartphone into a medical-grade sensor. The platform is coupled with a remote HIPAA-compliant SaaS platform, to cut hospital costs while generating revenue through Remote Therapeutic Monitoring, simultaneously providing integrated, personalized, portable medicine that enables new highly scalable community-wide preventative care systems and value models.
AltaSeal is a minimally invasive, mechanical occlusive permanent contraception device. The device requires no anesthesia, no hormones and is a quick 30 minute procedure placed in the office setting using a standard or disposable hysteroscope.
Alucent Biomedical is focused on transforming the way vascular disease is treated. The company is developing a proprietary catheter-based solution called Natural Vascular Scaffolding (NVS). The technology utilizes photoactivation of a small molecule drug delivered endovascularly to create a natural, stent-like scaffold using the body's own tissue and processes.
Myles Greenberg, President & CEO Alucent Biomedical
Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average.
Brio is a cavitation-enhanced low-power ultrasound lithotripsy system for office-based kidney stone treatment without anesthesia or fluoroscopy. The mapping and locating ureteral catheter delivers patented Briosphere microbubbles and ensures beam alignment with the stone. The treatment can be delivered anywhere in a simple, 30-minute procedure. Brio addresses a massive urolithiasis market and huge access and health equity gaps with a reimbursable single use procedure kit.
AppMed's APPY platform is a software solution that allows patients and their healthcare providers to optimize pharmacological treatment strategies for patients with ADHD. The solution computes and visualizes pharmacokinetic profiles of various drug combinations that maximize drug treatments in combination with routinely submitted patient-specific data to optimize patient care.
Aqua Heart is developing an over-the-wire, single shot ablation solution for the treatment of atrial fibrillation (AFib). The technology combines radiofrequency and balloon elements to bring familiar thermal ablation via a new technique that is a safe and fast way to perform pulmonary vein isolation.
ARC Medical has the only liquid medical device which forms a temporary barrier film to prevent surgical adhesions throughout the entire surgical area. ARC Medical’s products are backed by positive Phase 1 clinical trial safety data in 76 participants and superior nonclinical efficacy data in head-to-head comparisons against 3 of the top marketed products. Surgical indications include gynecological & abdominal and orthopedic surgeries – knee, shoulder & hip.
Arga Medtech is developing a next-generation solution for the treatment of cardiac arrhythmia and atrial fibrillation. The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today.
Arrayus Technologies is developing an image-guided ultrasound platform to enable incisionless therapeutic procedures. The company's technology uses intersecting beams of sonic energy to induce a range of biological effects, including tissue destruction, immunomodulation, drug delivery, and radiosensitization. Arrayus' solution is being developed for a broad range of oncological indications.
Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage.
ATRO Medical's Artimis prosthesis is intended to provide patients who are too young for a knee replacement yet suffering from chronic knee pain with a viable solution. Artimis is a flexible, artificial meniscus that offers patients a less invasive alternative for treating chronic knee pain.
Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults.
BioCorteX is a techbio that applies deep technology to deliver effective therapeutics and rewrites Eroom's law by leveraging the synergy between drugs and bacteria. BioCorteX exists because current drug development fails individuals by ignoring the (un)desirable drug-microbiome and pathophysiology-microbiome interactions. The company's lead product, Carbon Mirror™ uses deep tech to simulate how the colossal number of microbiota interact with a drug, de-risking preclinical studies and clinical trials, and replacing uncertainty with confidence for the patient.
BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.
BioT's cloud platform simplifies the creation of a connected care ecosystem. The platform is self-service and requires no coding to connect medical devices, patient management portals, caregivers, and EHRs in an integrated space.
Body Vision's fusion imaging platform enables pulmonologists, for the first time, to use all the existing imaging modalities together, in real time, without changing or affecting the procedural flow. The Body Vision System, together with a unique delivery device, enables the physician to plan the procedure, navigate to challenging locations and localize the lesion during biopsy. This complete solution will facilitate early-stage diagnosis of lung cancer and, in addition, will pave the way for minimally invasive transcatheter therapeutics.
Bold Type mission is to help companies solve hard technical problems. The company specializes in transforming proof-of-concepts into protoypes, with a specific emphasis on digital health applications and connected, wireless medical devices.
Jose Bohorquez, President Bold Type Product Development
BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians.
CAIRA is developing software for advanced joint replacement. The software utilizes radar technology to improve navigation during manual and robotic surgery. The company's first product is a navigation system for use during knee replacement surgery.
CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins.
CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue.
CardiaCare is developing a closed-loop neuromodulation device for the monitoring and prevention of atrial fibrillation. The wearable device utilizes medical grade artificial intelligence predict and deliver personalized, non-invasive electrical stimulation to the median Vagus nerve to reduce the occurrence of premature atrial contractions that are a precursor to episodes of atrial fibrillation.
Carecam is a digital health startup developing AI-powered solutions to identify gait disorders. The company has created a wearable-free solution that utilizes software and AI vision to analyze a patient's gate for neurology, orthopedic, and rehabilitation practices.
For industry partners bringing innovative solutions to market: Caresyntax offers clinical data services, data science expertise, and AI-enabled tech modules to collect meaningful data straight from the point of care. The company's services capture value for the end-user and produce actionable insights to drive commercial growth and product development needs.
Bruce Ramshaw, Chief Medical Informatics Officer Caresyntax
Caretaker Medical’s VitalStream™ Wireless Hemodynamic Monitoring platform is FDA-cleared to Non-invasively measure Continuous Beat-by-Beat Blood Pressure, Cardiac Output, Fluid Response, and other Advanced Hemodynamic parameters for ICU-quality continuous Remote Patient Monitoring across the full care continuum.
The company’s patented Pulse Decomposition Analysis™ AI Technology, wearable Finger Sensor and remote App provide a wire-free alternative to invasive A-Lines and catheter-based hemodynamics and eliminates blind-spots between intermittent measurements to enable early warning of deterioration and guide better clinical decision-making.
CARI Health is developing a next-gen wearable remote medication monitoring solution. The device will enable clinicians to view medication levels in real-time, customize dosages for patients, and keep them compliant on life-saving medications. The first application will be for patients being treated with medications for opioid use disorder to ensure treatment compliance remotely, without frequent clinic visits.
Accidental catheter removal can produce significant costs and complications for patients and providers. With nearly 25% of hospitalized patients requiring an indwelling catheter, there is a need for a better solution to prevent burdensome complications associated with these commonly used devices. CathConnect's solution allows existing Foley catheters to be transformed into devices that can easily breakaway without causing complications for patients.
A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
CeQur is a medical device company committed to simplifying the lives of people with diabetes by commercializing advanced, simple-to-use insulin-delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. Our product, CeQur Simplicity™, is an injection-free insulin delivery solution backed by years of research, patient trials, and clinical data.
Clarix Imaging is developing a solution to improve the outcomes of cancer surgeries. The company's volumetric specimen imaging system, VSI-360, generates 3D images of specimen in real-time to allow surgical oncologists to visualize tumors in the operating room. The technology allows surgeons and radiologists to visualize specimen margins without overlapping tissues obscuring the margins, and ultimately, improve patient care.
ClearCam develops technologies to improve the visual field-of-view during minimally invasive procedures. The company's ClearScope device is a disposable intra-operative lens cleaning device that continuous cleans and clears the lens of laparoscopic imaging systems during procedures, without having to remove the scope from the body cavity.
ClearIT is an emerging medtech company developing a new, painless, single treatment for tattoo removal. The company's ERASER System is a non-laser-based approach to tattoo removal. The device dislodges tattoo ink at room temperature through the creation of a benign, safe reactive energy field that works regardless of tattoo or skin color.
Cognoa is a pediatric behavioral health company that is using artificial intelligence (AI) to power digital diagnostic and therapeutic products. The company's lead product, Canvas Dx, is an FDA-authorized diagnostic aid for early autism diagnosis. Other products in development at Cognoa include a therapeutic solution for autism, as well as diagnostic and therapeutic solutions targeted speech disorders, ADHD, and anxiety.
Cordex Systems is developing a novel cardiovascular diagnostic device known as the SmartCuff. It is a quick, simple, non-invasive device that takes the direct measurement of vascular health out of a surgical cardiac catheterization lab and makes it accessible to both a consumer at home and a clinician in the office setting. Known as the “vital vital sign”, the vascular compliance measurement taken by the SmartCuff may be used to track direct changes in vascular health as people engage in healthy lifestyle choices such as diet, exercise, stress reduction and smoking cessation or take prescribed medications to treat diabetes, hypertension, or abnormal lipids.
Kathy Magliato, CEO Cordex Systems
CorInnova is developing a minimally invasive, soft robotic cardiac device for the short-term treatment of acute heart failure. The device gently conforms to the heart's surface, applying compressions to increase cardiac output without contacting the blood - eliminating a major risk of thrombosis and stroke.
CorIT Medical is developing a solution targeting the most common patient complaint to ENTs - nasal obstruction. The company's CorIT device is a single-use surgical device for the reduction of inferior turbinates in patients with obstructed breathing.
CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery.
Cosm Medical is developing a gynecology platform solution, called Gynethotics, for the treatment of pelvic floor pain. The process involves the use of diagnostic solution to "mold and scan" the pelvic floor. Artificial intelligence is then used to evaluate and provide clinicians with a personalized prosthetic design that safely integrates within the pelvic floor. Finally, the personalized device is created using 3D printing technology. The Gynethotics' platform will be further supported by a digital health portal to help patients track symptoms and share actionable data with clinicians to improve patient outcomes through the continuum of care.
Cyclic Variations in Altitude Conditioning (CVAC) is a is an effort-free method for physical conditioning for individuals of all ages and activity levels to improve fitness. The CVAC process applies precisely composed rhythm-based changes to pressure, temperature and density of air to create waves of tension and relaxation. These changes simulate breathing, muscle contraction, and blow flow changes consistent with circuit, interval and strength training.
Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. Additional products in development include an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.
Delphinus Medical Technologies develop and commercialize ultrasound technologies specifically for the early detection of breast cancer. The company's flagship product, SoftVue, utilizes proprietary TriAD (triple acoustic detection) technology to capture reflection echoes from all directions around the breast while simultaneously gathering transmitted signals through the breast. SoftVue is specifically designed for use in women with dense breast, who have historically been inadequately served with conventional imaging modalities.
Diality is a medical technology company developing a smart hemodialysis platform designed to be as capable and flexible as in-center treatment, in a fully integrated, easy-to-use system that’s intended to be safe to operate in any environment, with enough versatility to allow healthcare providers to tailor treatment to each patient’s specific needs. The Diality Hemodialysis System’s compact footprint and mobility are intended to enable it to be easily integrated into – and transported within – any dialysis setting, be it acute-care hospital, dialysis clinic, transitional care unit, traditional home, or skilled nursing facility.
Dilon Technologies develops a wide range of innovative medical solutions to benefit patients around the world. The company's portfolio of products ranges from devices to support surgical oncologists to ensure successful tumor localization and removal, to devices to improve intubation and hemostasis.
DriQ Health is an internet-of-things (IoT) incontinence monitoring solution. The company's technology leverages sensor technology and artificial intelligence to monitor the state of a diaper or adult brief. DriQ Health provides end-users with real-time access to their data to providers work with their patients to improve their quality of life.
Echopoint Medical is developing a family of optical-fiber based sensors which integrate into microcatheters to guide and improve outcomes during interventional cardiology procedures. The company's iKor platform translates ultrasonic signals to measure blood pressure and flow to more accurately assess, diagnose and treat patients with coronary artery disease and coronary microvascular dysfunction.
Egg Medical was founded in 2014 to develop and market the next generation of radiation protection devices for hospital x-ray labs. The company's first product, the Egg Nest, reduces staff radiation exposure by >90%! We launched commercial sales in late 2019- and the R&D and commercial buildout continues.
Elixir Medical mission is to breathe new life into vascular interventions. To achieve said mission, the company is pursuing the development of its latest product, the DynamX Coronary Bioadaptor System. DynamX is designed to be a significant advancement compared to drug-eluting stents in patients with symptomatic ischemic heart disease. Other vascular interventions in development at Elixir include a site-specific antithrombotic therapy and a lithotripsy system to effectively manage calcium buildup.
Endologix is dedicated to improving patients' lives through innovative interventions for the treatment of vascular disease. The company's portfolio consists of novel products for the treatment of peripheral artery disease (PAD) and aortic aneurysm repair (EVAR).
EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits.
eXpanded eXistence HoloOPS platform combines mixed reality technology with artificial intelligence to optimize the surgical suite. The platform provides surgeons with on-demand access to data and visualizations previously inaccessible to them from within the OR.
Facet Dynamics is developing a next generation alternative to lumbar fusion procedures. Protected by 4 U.S. Patents, “Restore” is a unilateral lumbar facet replacement device, manufactured from the same materials used in today’s artificial hip and knee joints, and implanted in exactly the same fashion as that which occurs in contemporary lumbar fusion procedures.
Chris Sturm, President Facet Dynamics
FibriCheck combines photoplethysmography (PPG) and a smartphone to transform the way atrial fibrillation is detected and monitored. A medically certified algorithm processes the image captured data and obtain insights on heart rhythm as an alternative to electrocardiogram-based devices.
Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia. The company is building a purpose-built system that incorporates PFA, contact force sensing, electromagnetic localization, and artificial intelligence-enabled mapping capabilities to address the limitations of first-generation PFA technologies and deliver more efficacious therapy.
FIZE Medical is developing a patient monitoring platform to measure the health status of patients based off real-time analysis of urine output. The company is currently developing three products that are all based around the base iUO monitoring device. The iUO Plus and iUO DUOFLO are advanced iterations of the base model model, enabling monitoring of acute kidney injury, shock prediction, intraabdominal pressure monitoring, and other vital monitoring measures.
Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs.
Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. The company's innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently.
FluidAI is developing smart monitoring solutions to detect anastomotic postoperative complications early. The company's plug-and-play technology integrates seamlessly with existing peritoneal drains and catheters to provide physicians with active patient monitoring of leakage-related surgical complications.
GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution.
Shane Brown, Chief Commercial Officer GT Medical Technologies
Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration.
HAPPE Spine LLC, is a medical device development company that designs and commercializes innovative spinal implants utilizing the patented HydroxyApatite Porous PolyEtheretherketone (HAPPE TM ) material platform. This technology combines the benefits of hydroxyapatite for bone ongrowth, designed porosity for bone ingrowth, and the radiolucency of PEEK for post-operative radiographic assessment.
Harmonic Bionics is a robotics company developing exoskeleton solutions to improve and rehabilitate movement impairments due to neurological and musculoskeletal disorders. The company's lead product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to optimize upper-extremity rehabilitation.
Hidradenitis Suppurativa (HS) is an inflammatory skin disease that causes painful symptoms, particularly in difficult to cover parts of the body such as the armpits, buttocks and groin. Traditional dressings often fail to provide adequate protection, cause additional skin damage via adhesives, and are challenging for patients to apply. HidraWear is a wearable wound care system that provides HS patients with the necessary support to easily apply and manage their flares.
Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.
iChor Vascular's goal is to become the 1st-line therapy for treating peripheral vascular occlusions. The company's ICHOR Panacea technology is a versatile, catheter-based solution that provides rapid reperfusion to occluded vessels, without the need for thrombolytic drug therapies or complex surgery.
iiShield's mission is to improve short and longterm transplant outcomes. The company's lead product is a protective jacket for the kidney that aims to increase the amount working time available to surgeons during transplant procedures. The device protects kidneys from heating up during surgery, reducing the amount of thermal injury to these vital organs and minimizing risks of complications.
ImaCor designs, manufactures, and distributes a hTEE (hemodynamic transesophageal echocardiography) ultrasound system to enable clinicians to optimize cardiac interventions by enabling clinicians to guide and assess the effectiveness of therapies and make critical changes to patient management at the right time.
inHeart's technology generates a 3D map of the patient's heart from medical images to provide physicians with a highly detailed anatomical map, including structural substrate for both ventricles and atria.
InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics.
Innova Vascular develops medical devices for the treatment of thromboembolism. The company's portfolio of vascular interventions include aspiration catheters and clot retrievers for the treatment of arterial and venous thromboembolism.
Innoventric id developing an easy-to-use, reliable, and safe percutaneous solution for the treatment of tricuspid regurgitation. The company's Trillium device uses cross-caval anchoring and a unique, multi-valve design to fit a wide range of anatomies without the risks of migration and leaks.
Interventional Systems is improving patient outcomes by expanding access to minimally invasive robotics. The company's miniature robotic platform, Micromate, is designed to support interventional radiologists and oncologists with an easy-to-mount system that integrates into existing operating rooms. The Micromate platform offers single and multi-needle, device agnostic interventions supported by the submillimeter accuracy and corrective capabilities of robotics.
IntraOp Medical is focused on the development and commercialization of portable electron-beam intraoperative radiation therapy (IORT) systems. The company's flagship product, Mobetron, is a mobile, self-shielded LINAC machine for treatment of cancer patients during surgery.
INVENIO's NIO Laser Imaging system uses Stimulated Raman Histology to image unprocessed tissue specimen without requiring sample preparation to enable histological evaluation of tissue outside of a laboratory.
Jay Trautman, Co-Founder, CEO & Director Invenio Imaging
InVera Medical is developing a catheter-based therapy for chronic venous disease. The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels.
At IQ Endoscopes, we are creating pioneering, sustainable endoscopy technologies for the early diagnosis of diseases, helping to create a world where everyone has access to sustainable sterile endoscopy. Our Single Use Gastroscope is currently under regulatory review and this will be quickly followed by regulatory submissions for our single use colonoscope and sigmoidoscope in 2024. This compelling platform will enable IQ Endoscopes to offer healthcare professionals the most comprehensive range of single use technology to address the Gastro Intestinal market, whilst also ensuring key sustainability requirements are surpassed. With commercial activities set to begin in 2025, the organization is at a very exciting stage.
Jana Care is developing self-administered testing technologies for chronic kidney, heart disease, and diabetes management. The platform enables patients to self-administer blood tests at home, and clinicians can remotely review the test results as needed. The platform’s capabilities aim to overcome distance and socioeconomic hurdles that currently hinder the timely detection and monitoring of chronic kidney and heart disease progression.
JelikaLite is a clinical stage medtech company developing a neuromodulation platform that addresses unmet needs in developmental pediatric disorders. The company's Cognilum device is a wearable therapeutic device that provides non-invasive brain stimulation using near-infrared light to improve responsiveness, speech, and social interaction in children with autism.
Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery.
Sanjeev Bhatia, CEO Joint Preservation Innovations
The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure.
Kent Imaging is using multispectral oxygenation imaging to enhance the care of chronic wounds. The company's lead product, SnapshotNIR, is a portable tool that utilizes near-infrared (NIR), reflectance-based technology to measure tissue oxygen saturation in superficial tissue. The information collected by the device improves the data available to care providers when making medical decisions that positively impact patient outcomes in wound care.
Kneevoice has designed a platform technology to capture the noise generated by the knee to evaluate cartilage damage and diagnose osteoarthritis. The platform consists of wearable knee sensors that records the sounds generated by the knee. This data is collected an analyzed by a neural network algorithm and generates a score evaluating the status of the cartilage.
Lazurite's ArthroFree system is a wireless surgical camera designed to address the limitations of traditional arthroscopic camera systems. Lazurite's technology removes the need for fiber-optic cables, helping to improve efficiency without compromising image quality. At the heart of the company's technology is the proprietary Meridiem light engine, a novel light source that does not require cables to transmit light and images during surgical procedures.
Lazzaro Medical has developed a minimally invasive surgery for the treatment of Tracheobronchomalacia (TBM), a degenerative disease that causes the complete, or near-complete, collapse of the airway due to cartilage breakdown in the trachea. The LM Scaffold System restores the patency of the trachea, improving breathing through a simple procedure conducted via a robotic system. The company is pursuing a platform approach to the treatment of TBM and other pipeline indications with the development of a diagnostic tool to simplify diagnosis and an endotracheal tube to improve the efficiency of respiratory surgeries.
LEADOPTIK is developing an image-guided biopsy needle for early-stage lung cancer detection. Clinical challenges persist in integrating technology and tools to safely and effectively reach the peripheral lung. The company is introducing metasurface technology to caregivers, enabling real-time nodule assessment (RTNA) during biopsies.
Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software.
LINLINE Medical Systems has over two decades of experience in the design and production of medical lasers. The company's flagship product, MULTILINE, is a multi-application, modular platform equipped with five external high-intensity lasers intended for use in aesthetics, dermatology, and surgery.
Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops.
Lionheart Health is using targeted bioelectric treatment to stimulate the body's natural healing and regeneration. Specific bioelectric signaling sequences have been shown to promote the expression of proteins for cosmetic purposes, as well as in pathways related to brain, muscle and nerve regeneration. The core stimulation technology has been purposefully implemented into a number of wearable devices targeting specific clinical indications.
Liquet Medical's mission is to transform the way vascular disease is treated. The Versus Catheter features dual tips that enables treatment of both lungs, in addition to real-time pressure monitoring sensors which allows physicians to optimize the amount of drug delivered while limiting potential side effects.
Lucid is developing solutions to help clinicians diagnose and manage the progression of esophageal disease. The company has developed to solutions that allow clinicians to effortlessly collect and analyze esophageal cells to identify Barrett's Esophagus.
Lumicell is focused on innovative fluorescence-guided technologies for cancer surgery. The company's Lumicell Direct Visualization System is intended to guide the removal of residual cancer during surgery in real time. The platform technology consists of an optical imaging agent, a handheld device, and patient-calibrated tumor detection software that work together to find, view and guide the resection of residual cancer. Lumicell is currently investigating the use of its technology for use during breast cancer surgery.
Lumiheal Therapeutics is harnessing the power of fluorescent light energy to heal chronic and acute wounds, burns and surgical incisions. Our mission is to make highly effective advanced wound therapies affordable and accessible to all.
Howard Walthall, Founder & CEO Lumiheal Therapeutics
Lungpacer Medical is focused on empowering patients to breathe on their own following mechanical ventilation. The AeroPace System harnesses the body's nervous system via catheter-based stimulation of the phrenic nerves to rebuild diaphragm muscle strength and wean patients off ventilators faster.
Magenta Medical is developing miniaturized solutions for the treatment of acute and chronic heart failure. The company's lead product, Elevate, is a percutaneous Left Ventricular Assist Device (pLVAD) is a self-expanding, catheter-mounted arterial pump comprised of a thin memory-shape metallic frame and a soft, flexible material that forms the body of the blades. The device is intended to provide temporary mechanical circulatory support for the left ventricle.
MALCOVA is utilizing proprietary computed tomography technology to provide a safe, comfortable, and effective imaging solution for the early detection and diagnosis of breast cancer, particularly in women with dense breasts. This technology is at the heart of a three-pronged approach that leverages the company’s advances in hardware, AI-based software, and patient-surrogate phantoms to yield a significant paradigm shift in the way breast cancer is detected and treated.
Method AI is developing a surgical navigation platform to drive improved patient outcomes for robotic oncology procedures. The company’s product will leverage deep tissue imaging and machine learning algorithms to provide physicians with real-time guidance against an AI-generated surgical plan.
MicroTransponder's Vivistim tool treats patients who experience upper limb problems after a stroke by delivering a small amount of neurostimulation to the vagus nerve to strengthen neural pathways in the brain during rehabilitation. The device comprises a small implanted battery and wires that internally connect to the vagus nerve in the neck. In addition to the Vivistim system, the company is evaluating its Serenity system as a treatment to treat and reduce tinnitus over time.
MIMOSA has developed a tiny, hand-held device that democratizes the collection of tissue information in patients with peripheral vascular disease (PVD), wound care, diabetes, burns, and potential post-operative surgical complications. The device is capable of detecting tissue oximetry and temperature through the use of multispectral imaging, letting healthcare providers visualize beneath the skin, regardless of the patient's location.
Dr. Karen Cross, Co-Founder & CEO MIMOSA Diagnostics
Modulim’s mission is to help clinicians prevent the onset or escalation of diabetic foot ulcers—and other complications of vascular compromise. The Clarifi device is a noninvasive, non-contact, diagnostic wide-field imaging system that provides a fast, reliable, and objective method of assessing tissue oxygen saturation, hemoglobin quantity, and distribution at different depths in patients with compromised circulation.
MOLLI Surgical started in the OR after recognizing that surgeons were using dated technologies to treat cancer patients. The company's technology eliminates the need for wires and radioactive seeds for tumor localization with a magnetic-based system that is precise, reliable, and easy-to-use.
MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.
N8 Medical is incorporating active compounds called ceragenins into medical devices to address unmet needs in patient care related to infections and other complications associated with medical devices. The company's lead product, CeraShield, is a biofilm-resistant endotracheal tube designed to reduce ventilator associated respiratory infections. N8 plans to employ the use of ceragenins into other medical devices that can benefit from the antimicrobial and anti-inflammatory properties of these small molecules.
Nanoflex Robotics is developing next-generation, remote robotic solutions to enhance access to life-saving procedures. The company's robotic system uses advanced magnetic technology and ultra-flexible endoluminal tools to enable faster and easier navigation through tortuous blood vessels. Nanoflex's initial target application aims to shorten the time to treatment for acute ischemic stroke by making remote mechanical thrombectomies a reality.
NanoHive's proprietary spinal fusion Soft Titanium technology addresses the challenges of spinal fusion with a bioactive, 3D-printed, titanium interbody device. The design of the device grants it the flexibility of PEEK while providing similar load bearing strength comparable to bone.
NasaClip is an adjustable nosebleed rescue device designed to provide constant, comfortable, hands-free compression. The NasaClip device combines intranasal sponges and external nasal pressure to compliment and support the body's natural clotting process.
Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement.
Plant-based human skin substitute in either a protein material bandage or a "no-touch" application protocol device (especially for burns) that is lightweight, portable, military-grade and available at any point of injury to deliver skin substitutes along with other therapeutics for military and civilian patients.
NeuraLace Medical are the developer's of Axon Therapy, an FDA-cleared solution for the management of chronic pain. Axon Therapy uses noninvasive, magnetic pulse technology to treat chronic nerve pain in patients recovery from injury or surgical procedures.
Neuro42 is developing a point-of-care, portable MRI platform backed by artificial intelligence and robotics. The platform will utilize low-field MRI imaging technology to enable imaging across departments, as well as support surgical procedures with live image guidance.
Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration.
NirvaMed is an early-stage medtech company developing a novel treatment for ST-Elevation Myocardial Infarction (STEMI). The company's solution is a rapid cooling system that can be deployed in parallel with standard devices for PCI to enable cardiac tissue preservation that addresses the shortcomings of previous hypothermic treatments. The device is delivered to the right side of the heart to prevent disruptions to standard left side of the heart procedures to provide ischemic relief prior to reperfusion therapy.
NovaResp is developing technology to improve the prediction of respiratory events in patients using positive airway pressure (PAP) machines. The company's platform uses artificial intelligence and machine learning to monitor respiration and prevent detrimental episodes of apnea.
Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation.
Henry (Chip) Appelbaum, President & CEO Novian Health
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
NOxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative capabilities of nitric oxide (NO) to heal chronic wounds. Due to various factors, the body can lack the natural ability to produce and deliver sufficient NO. The company is investigating topical means to deliver NO exogenously to improve oxygen and nutrient flow to wounds, promote healthy inflammation, and stimulate the development of new microvessels and tissue.
Nurami Medical is a developer of soft tissue repair technologies that leverage the company's expertise in brain physiology, nanofibers, and biomaterials. Nurami's technology utilizes a combination of electrospun nanofiber scaffolds and advanced bioactive materials. The company's flagship product, ArtiFascia, is a synthetic dural graft intended to facilitate the healing of the dura after cranial neurosurgery by creating an effective barrier that prevents harmful CSF leaks in dura repairs.
Peter Stebbins, Executive Chair of the Board Nurami Medical
Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.
Nuubo is a textile electrode for mid- to long-term ECG monitoring. The Nuubo system simplifies collection of ECG data compared to traditional, wire-based systems. Composed of a flexible material that adapts to the wearer's movements, Nuubo does not restrict daily physical activities and enables the capture of new cardiac insights based on the expanded range of physical data available to clinicians.
Implantable ports are at increased risk of complications that cost healthcare systems and patients over $2 billion dollars annually. To address the challenges inherent to implantable ports, NXgenPort have developed a smart port that remotely monitors and reports physiological changes in vivo. The device enables better patient management and early intervention, and ultimately, better clinical outcomes.
OnPoint Surgical is revolutionizing orthopedic and neurosurgical spinal procedures with an Augmented Reality (AR) platform technology that superimposes virtual surgical guides and virtual spinal implants onto the surgeon’s visual field using see-through optical head-mounted displays. The technology offers many unique clinical and intra-operative benefits including intuitive use, improved hand-eye coordination, and impressive accuracy with the potential for better clinical outcomes.
Opsin Biotherapeutics is a joint venture that combines the expertise of Nanoscope Technologies with DesignPlex Biomedical to create unique products and alternatives to opioids and spinal cord stimulation for the treatment of chronic pain. Opsin's therapy specifically targets and activates the neurons that block pain through the delivery of light sensitive proteins that are activated via a low power LED light.
Robert Benkowski, Co-Founder & CEO Opsin Biotherapeutics
Orthomod's mission is to develop the next generation of orthopedic biomaterials. The company is combining natural and synthetic orthobiologics with polymer components to create implants for orthopedic and spinal surgery.
Diality is a medical technology company developing a smart hemodialysis platform designed to be as capable and flexible as in-center treatment, in a fully integrated, easy-to-use system that’s intended to be safe to operate in any environment, with enough versatility to allow healthcare providers to tailor treatment to each patient’s specific needs. The Diality Hemodialysis System’s compact footprint and mobility are intended to enable it to be easily integrated into – and transported within – any dialysis setting, be it acute-care hospital, dialysis clinic, transitional care unit, traditional home, or skilled nursing facility.
Ossiform uses proprietary technology to 3D print patient-specific, natural, and resorbable bone implants. P3D Bone PSI is a fully resorbable bone graft substitute that features a unique bone-like porosity that remodels in real living bone. P3D Bone demonstrates osteoconduction with the rapid formation of new vascularized bone that osseointegrates with native bone, while simultaneously balancing bioresorption.
Monica Wellejus, Sales and Marketing Manager Ossiform
Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients.
OUI Medical's micro-peritoneoscope is a disposable, portable handheld scope that includes an integrated camera, screen, processor, battery and biopsy forceps. The technology enables peritoneoscopy under local anesthesia at the point-of-care.
Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.
Oxford Medical Products is developing a safe, effective, and affordable solution for weight loss. The Sirona solution consists of a self-expanding capsule that delivers a hydrogel into the stomach to create a sustained feeling of satiety. The hydrogel remains in the stomach for several days before degrading and being naturally digested.
The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates.
Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.
Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration.
Positrigo is developing a functional positron emission tomography (PET) system with a small footprint at a fraction of the cost of current PET scanners. The company's NeuroLF system is an ultra-compact, dedicated PET system for applications in neurological (e.g., dementia, epilepsy) and neuro-oncology.
Prana Thoracic is developing an innovative approach to improve the early diagnosis of lung cancer. The company is developing the ThoraCore System, a CT-guided, catheter-based approach to perform a nodulectomy. The technology will be capable of safely coring, capturing suspicious pulmonary nodules, while sealing lung tissue using bipolar radiofrequency energy.
PredxBio is converging spatial analytics and artificial intelligence to transform precision pathology. The PredxBio Platform is an analytical software that is capable of predicting tumor initiation, progression, and response to therapy - enabling better outcomes for patients. With PredxBio, drug discovery and clinical development is enhanced with spatially intelligent biology.
Pretika MedTech is reimagining outpatient and inpatient care with AI-powered Connected Wound Care technology. The company's non-invasive, embedded medical device and wireless digital care cloud platform provides on demand or continuous imaging, sensor and data analytics for physicians and nursing teams to monitor post-surgery, wound and disease healing remotely or in-person without having to remove the surgical dressings, bandages, wraps or casts.
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.
Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along with devices that accelerate healing, to rapidly close chronic non-healing wounds. The wound management platform consists of a nanotechnology wound gel dressing formulation (HemastylRx) and Gen-Ray, a device to apply mild-heating to the wound to accelerate absorption and stimulate the healing process.
RedDrop is a virtually pain-free, cost-effective, and easy-to-use whole blood and plasma collection system. The device, which can be used in home and healthcare settings, is capable of collecting high quality blood samples for diagnostic testing and remote clinical trials.
Regain Laser Therapy is a US-based medical device platform company with a strategic focus on regenerative medicine. The company is developing a proprietary, non-invasive, portable laser platform - the Regain Warrior. The tecnology is being designed to address limitations of the standard of care.
Relavo's mission is to improve the lives of people living with kidney failure. The company is changing the way people receiving peritoneal dialysis (PD) receive dialysis with its innovative in-line connection device - PeritoneX. Compatible with existing PD systems, PeritoneX internally disinfects dialysis tubes at all connection sites, preventing peritonitis and the costs associated with managing infections.
SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.
Samay uses a patented acoustic resonance technology to manage respiratory patients at-risk of exacerbations. Our first product, Sylvee, is a wearable sensor platform that continuously, passively and non-invasively monitors over 10+ lung function parameters in real time for 10x less than hospital-based testing
Scalpel's digital platform has been designed to address key challenges and improve the operation of the operation room. Using artificial intelligence (AI) and noninvasive sensors, Scalpel helps hospitals and providers manage inventory, optimize instrument trays, and provide detailed peri-operative data analytics.
Sentante is developing a teleoperated/remote surgical robot for the performance of fully-robotic endovascular interventions. Artificial intelligence (AI) will enhance the capabilities of the system, enabling the performance of routine tasks during interventional cardiology procedures such as guidewire and catheter exchanges.
Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.
Should Innovations' mission is to provide innovative solutions that address current challenges in shoulder arthroplasty. The company's flagship product, the InSet Glenoid Implant has been designed to address the most significant issue in shoulder arthroplasty - glenoid loosening. Since the introduction of the initial InSet Implant, the company has gone on to introduce additional products to continue to address unmet needs in shoulder repair.
SmartHealth Dx develops precision diagnostics that address unment needs in chronic diseases. The company is focused on how pathology tissue sample images are prepared, processed and viewed. SmartPath Dx is a rapid glass slide-free pathology instrument that produces high-quality digital images within minutes and allows sample tissue to remain intact. The company's technology is being implemented into multiple clinical applications, including cardiovascular disease, metabolic diseases, and oncology.
Smartlens has developed a device to enable "on the go" measurement of intraocular eye pressure. The company's flagship product, miLens, is an electronics-free device that provides seamless measurement capabilities to improve the early diagnosis of eye disease, certain neurological disorders, and cancers. In addition to the miLens product, the company's THERmic device applies micro-doses of personalized treatments for the treatment of glaucoma.
Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.
SpinaFX Medical is committed to bridging the therapeutic gap (conservative vs. surgery) in the treatment of back and leg pain caused by a contained herniated disc. The company is pioneering a minimally invasive, image-guided treatment that injects a mixture of oxygen and ozone gas to reduce herniated disc volume. Clinical data shows that the solution leads to a reduction of disc volume, which relieves nerve root compression and herniated disc-related pain.
Stimdia's pdSTIM system has been designed to electrically stimulate the phrenic nerves in a patient's neck to exercise the diaphragm during mechnical ventilation and minimize the impact of ventilation-induced diaphragmatic dysfunction. The temporary pacing stimulation is intended to support patients who have been ventilated for over 96 hours.
SurePulse has identified a critical need for vital signs monitoring solutions for newborn babies. Current technologies have been adapted from devices for children and adults and are not suitable for newborn babies due to multiple factors. To address this limitation, the company has designed the SurePulse VS system, which uses a medical cap fitted with sensors to continuously monitor neonatal vital signs.
Switfsure Innovations is addressing the challenges in caring for ventilated patients in critical care. The company's first product is being developed to improve oral care and reduce the incidence of ventilator-acquired pneumonia and its associated complications due to poor oral care.
TAE Life Sciences, a subsidiary of TAE Technologies, is leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy (BNCT) to bring promising treatment potential for head and neck, glioblastoma multiforme (GBM) and other cancers that are difficult to treat with traditional methods.
Tally Surgical is developing a next generation solution to track and manage retained sponges in the operating room. Tally is designed to be a reliable, easy-to-use, and cost-effective retained sponge solution. The product provides OR staff with an accurate count of surgical sponges more efficiently than current solutions.
The Patient Company is reimagining the way that patients are moved with SimPull. As the first new patient movement platform in over 20 years, SimPull automates the movement of patients, beginning with lateral patient transfer, and is the first patient movement device that stores and shares data on patient movement. This data provides insights that inform patient movement activities while simultaneously reducing liability for caregivers and hospitals in a new, unique way.
The Shape Sensing Company is seeking to take minimally invasive surgery into the next generation. Shape sensing technology utilizes fiber optic sensors to detect the shape and location of medical devices (e.g., catheters, endoscopes) within the body. The company's technology will minimize the complexity associated with traditional instrument navigating and tracking methods, such as fluoroscopy and ultrasound, while providing clinicians with comprehensive instrument tracking data.
Ryan DeBoer, Managing Director The Shape Sensing Company
THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant.
ThinkSono is democratizing access to ultrasound devices. The company's ThinkSono AI platform uses artificial intelligence to guide and empower training with ultrasound at the point-of-care – allowing non-specialists to rapidly learn how to perform ultrasound examinations. Beyond ultrasound training, the company is developing AutoDVT, an AI-enabled solution that enables healthcare professionals to perform point-of-care scans for Deep Vein Thrombosis using a handheld ultrasound transducer and mobile phone.
Total Flow Medical is developing solutions to improve outcomes during patients undergoing heart surgery. The company's initial product is an easy-to-use cannula for use during minimally invasive cardiopulmonary bypass surgery. The device is being designed to improve the current clinical wokflow and patient quality of life.
TrackX Technologies is enhancing surgical instrument tracking with real-time, virtual live fluoroscopy. The company's Snap device provide visual guidance and real-time instrument tracking of the jamshidi needle during percutaneous pedicle screw placement procedures.
Trukera Medical is building a portfolio of products to address unmet needs in eye care for patients and providers. The company's ScoutPro osmolarity system is a handheld osmolarity testing device for the detection of toxic hyperosmolarity, a condition which damages corneal cells and drives refractive instability.
Vektor Medical's vMAP system helps identify the sources of stable and unstable arrhythmia using ECG data. Clinicians upload ECG data into the vMAP system, which then interprets and visualizes the data in 3D to identify sources of arrhythmia inside and outside of the heart. The vMAP system is capable of creating a "heat map" of the heart in minutes to support or improve ablation treatment planning.
Vena Medical is developing solutions to improve the way stroke is treated. The company's MicroAngioscope camera is capable of going inside the veins and arteries to visualize diseased lesions and help physicians treat stroke. The Vena BDAC system combines a balloon guide catheter with a distal access catheter to allow physicians to get closer to clots faster and more efficiently.
Vena Vitals is an early stage med-tech company focused on non-invasive continuous blood pressure monitoring. The company's proprietary technology is a soft flexible sensor that conforms to the skin for direct pressure measurement at theradial artery. The company's technology is intended to replace unnecessarily invasive arterial line measurements as well as non-continuous cuff-based methods in both the hospital and at home.
Versono is developing an intravascular ultrasonic platform to improve the crossing of severe occlusions in the peripheral vasculature. The device will prepare a working lumen to support endovascular therapy in patients with chronic total occlusions (CTOs) and critical limb ischemia (CLI).
Vessl is providing a solution for the hundreds of thousands of amputees that struggle to adapt to loss of limb. The company is designing an automatically adjusting prosthetic socket which redistributes pressure around the leg in response to changes in limb size. The isoform prosthetic socket will improve quality-of-life for thousands of patients - allowing them to lead active and fulfilling lives.
Veyond Metaverse is a healthtech company building a platform for medical education, remote surgical training and collaboration utilizing extended reality (XR) and artificial intelligence (AI). The platform is designed to be used in a variety of surgical specialties for both open and minimally invasive procedures.
Formerly known as Advanced Scanners, VISIE is a 3D computer vision and spatial computing company researching, developing, and commercializing revolutionary optical scanners for robotic and navigated orthopedic, neuro, and spine surgery. VISIE’s proprietary imaging hardware and software combines the power of optical physics and deep tech to make the unseen seen in surgery.
Visura manufacturers the world's first, FDA-cleared, disposable camera, the TEECAD System, that seamlessly connects to a transesophageal echocardiogram (TEE) echo probe, providing physicians real-time visualization for more efficient and effective probe placement for safer intubation.
Vitestro, expert in medical robotics, was founded in 2017 to develop a device for autonomous blood collection in patients. The device combines ultrasound-guided 3D reconstruction based on AI with venipuncture. The procedure is fully automated, from tourniquet to applying a bandage. The premise for this innovation is to create a safe and consistent patient experience parallel to working towards a positive impact on solving the increasing shortage of healthcare personnel.
Vomaris is harnessing the capacity of bioelectronics to develop solutions to support wound healing and reduce the risk of infection. V.Dox Technology generates electricity via a matrix of moisture-activated microcell batteries. The electric current mimics the skin's physiological electric energy to kill broad-spectrum pathogens found in conventional dressings.
Vonova are improving access to care for patients afflicted with drug-resistant epilepsy. The Cerebro Atlas System uses the body's natural venous pathway to deliver an expandable neural interface that covers the region of the brain to identify seizure activity.
Wearable Artificial Organs is developing truly portable solutions for use in patients with End Stage Renal Disease (ESRD). The company has currently prototyped two wearable device, a cordless continuous renal replacement therapy (CRRT) system and a wearable artificial kidney.
X-Bolt develops next-generation devices for use during trauma surgeries. Key to the company's portfolio of orthopedic products are its expanding bolt design and the ability to easily reverse and remove implanted devices.
Zeto's electroencephalogram (EEG) is an FDA-cleared alternative to traditional EEG setups. The company has developed a wearable headset that is wireless, eliminates the need for preparation (e.g. gel application), and fully integrates with cloud data systems for real-time data viewing and management.
New procedure to mimic the clinical effects of tibial osteotomy procedures. Implants will be delivered to the proximal tibia below the patellar tendon, offloading and re-directing the tendon to reduce pain and inflammation.